SolGold plc: Grant of Share Options

LONDON, UNITED KINGDOM–(Marketwired – Aug 9, 2017) – SolGold plc (TSX: SOLG)

TSX: SOLG

9 August 2017

SolGold plc
(“SolGold” or the “Company”)

Grant of Share Options

The Board of SolGold plc (SolGold or the Company) wishes to advise of the grant of a combined total of 46,762,000 unlisted share options over ordinary shares of the Company, including:

i. 36,750,000 share options to Directors (or their nominees) following approval granted by shareholders at the Company’s AGM on 28 July 2017; 
ii. 10,000,000 share options to its two key geologists; and 
iii. 12,000 share options to a third party as part of the capital raising fees for the Company’s last equity placement.

All of the share options have a strike price of 60 pence, and expire on 8 August 2020. The share options for Directors and the geological executives have a vesting period of 18 months unless triggered by a change of control transaction.

Following the allotment of these share options, the Company has on issue a total of 1,515,555,686 fully-paid ordinary shares, 31,795,884 share options exercisable at 28p; 9,795,884 share options exercisable at 14p and 46,762,000 share options exercisable at 60p.

CONTACTS

Mr Nicholas Mather   Tel: +61 (0) 7 3303 0665
SolGold Plc (Executive Director)   +61 (0) 417 880 448
[email protected]    
     
Mr Karl Schlobohm   Tel: +61 (0) 7 3303 0661
SolGold Plc (Company Secretary)    
[email protected]    
     
Mr Ewan Leggat / Mr Richard Morrison   Tel: +44 (0) 20 3470 0470
SP Angel Corporate Finance LLP (NOMAD and Broker)    
[email protected]    

Follow us on twitter @SolGold_plc

Market Abuse Regulation (MAR) Disclosure

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

Click on, or paste the following link into your web browser, to view the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/4969N_1-2017-8-9.pdf

Contacts:
RNS
Customer
Services
0044-207797-4400
[email protected]
http://www.rns.com